SCIENTISTS will genetically modify humans for the first time in Europe after being given the go-ahead for a DNA-splicing therapy. Swiss-based biotech company Crispr Therapeutics hope to find a way of curing blood disease beta thalassaemia. It is caused by a mutation in DNA. Experts hope to cut this away and replace it with genetically […]
